Healthcare Network P&L Statement and Expansion Projects
MAX
Healthcare
Best in class performance parameters
ARPOB(1)
(INR/OBD) ('000)
Operating
parameters
59
75
90
I
67
Occupancy
(%)
75% 76% 74%
60
58
63% 64% 62%
67%
63%
64%
45
52
54
48
45
I Max Healthcare
Apollo Hospitals
Fortis
Max Healthcare
(Hospitals Business) (Hospital Business)
Apollo Hospitals
(Hospitals Business)
Pre-tax ROCE (2)
(%)
Operating EBITDA per bed (3,4)
33% 35%
Financial
parameters
29%
Fortis
(Hospital Business)
(INR lakh)
Op. EBITDA
Margin
27% 28% 27%
19% 20% 19%
15% 17%
15%
40
57
99
70
66
25% 25%
21%
10% 10% 9%
I
Max Healthcare
Apollo Hospitals
L
FY22
Fortis
FY23
41
44
37
32
27
32
27
32
Max Healthcare
I Apollo Hospitals
Fortis
_ J (Hospitals Business)
(Hospital Business)
Q1 FY24
(1) ARPOB calculated on gross revenue excluding revenue from Covid-19 vaccinations, non captive Pathology and Pharmacy; ARPOB of Apollo & Fortis is as published in their Earning's update | (2)
Indicative company level ROCE; Apollo ROCE is as published in their earning update for their consolidated financial performance; Fortis EBIT is computed from Group Consolidated P&L including share
of Profits in associates and Capital employed is after adjusting for cash & bank balances assuming 85% of that are held in short term FDRs | (3) Operating EBITDA excludes exceptional items and non
operating Income and non cash items | (4) Operating EBITDA per bed includes that from vaccinations in absence of information for other players and excludes that from non captive Pathology and
Pharmacy; Apollo revenue & EBITDA includes Indraprastha Apollo Delhi. The revenue has been grossed up for adjustment of doctor fees as per the disclosures in the last annual report of FY22 for the
calculation of operating EBITDA margin %
12View entire presentation